EGFR and K-ras mutations in cytologic samples from fine-needle aspirates in NSCLC patients Source: Eur Respir J 2012; 40: 267-269 Year: 2012
Feasibility of EGFR mutation testing on EBUS-TBNA and bronchial biopsy samples obtained during routine practice Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012
Interobserver agreement in determining non-small cell lung cancer subtype in specimens acquired by EBUS-TBNA}, Source: Eur Respir J 2012; 40: 699-705 Year: 2012
Accuracy of cell typing in nonsmall cell lung cancer by EBUS/EUS–FNA cytological samples Source: Eur Respir J 2011; 38: 911-917 Year: 2011
Adequacy of EBUS-TBNA specimens for molecular testing in lung adenocarcinoma Source: International Congress 2017 – EBUS Year: 2017
Correlation of p53, EGFR and HER2 expression in the diagnostic biopsies and the corresponding resected tumours in NSCLC Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003
EGFR and KRAS mutational profiling in NSCLC cells obtained through fine needle aspiration cytology (FNAC) Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
Histological subtyping of non-small cell lung cancer using transbronchial biopsy specimens obtained with a small forceps Source: International Congress 2017 – How to reach peripheral lesions: (radial EBUS, CLE, navigation, etc.) and treat airleaks Year: 2017
Telomerase activity in transthoracic fine needle biopsy specimens as a prognostic factor of survival in patients with non-small cell lung cancer (NSCLC) treated surgically or nonsurgically Source: Eur Respir J 2006; 28: Suppl. 50, 387s Year: 2006
Rinse fluid cytology specimens add value to standard bronchoscopic sampling techniques in the diagnosis of lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 361s Year: 2003
Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens Source: Eur Respir Rev, 26 (144) 170007; 10.1183/16000617.0007-2017 Year: 2017
HER-2/neu expression in bioptic and surgical samples of non small cell lung carcinoma Source: Eur Respir J 2002; 20: Suppl. 38, 3s Year: 2002
Cytology in differential diagnosis of histological types of NSCLC Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
PD-L1 determination in cytological and histological samples in patients with non-small cell lung cancer Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules Year: 2018
Is EBUS sampling adequate for molecular testing in patients with advanced NSCLC? Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020
Detection of k-ras mutations in cytologic specimen of lung cancer patients as predictive factor of targeted therapy Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
The prognostic value of the expression of GST-π in response to chemotherapy in cytological and pathological specimens of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 74s Year: 2002
Concordance of p53 and K-ras mutations in induced sputum and corresponding biopsies of patients with nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001
Diagnostic value of telomerase activity measurement in transthoracic fine needle biopsy (FNB) specimens of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 330s Year: 2005
The diagnostic relevance of cytologic examination of induced sputum in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 299s Year: 2004